Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$233.45 - $247.73 $9,804 - $10,404
42 New
42 $10,000
Q3 2023

Oct 17, 2023

BUY
$254.9 - $283.59 $5,862 - $6,522
23 Added 1.02%
2,285 $590,000
Q2 2023

Jul 21, 2023

SELL
$238.39 - $265.32 $1,668 - $1,857
-7 Reduced 0.31%
2,262 $597,000
Q1 2023

Apr 18, 2023

SELL
$229.71 - $259.35 $2,067 - $2,334
-9 Reduced 0.4%
2,269 $561,000
Q4 2022

Jan 17, 2023

SELL
$218.29 - $256.91 $66,796 - $78,614
-306 Reduced 11.84%
2,278 $0
Q3 2022

Oct 13, 2022

BUY
$51.03 - $264.23 $2,041 - $10,569
40 Added 1.57%
2,584 $576,000
Q1 2022

Apr 26, 2022

BUY
$243.64 - $270.48 $20,222 - $22,449
83 Added 3.37%
2,544 $677,000
Q4 2021

Jan 19, 2022

BUY
$230.08 - $250.94 $511,928 - $558,341
2,225 Added 942.8%
2,461 $619,000
Q3 2020

Sep 07, 2021

BUY
$215.77 - $276.76 $50,921 - $65,315
236 New
236 $55,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.